CINA-CSpine vs Rayvolve

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Avicenna.AI
VS
by AZmed SAS

AI Verdict

CINA-CSpine is an AI tool specifically designed for the rapid detection of acute cervical spine fractures on non-enhanced neck CT scans, making it suitable for detailed spinal trauma assessment. Rayvolve, on the other hand, offers broader AI-powered detection of general fractures and chest pathologies exclusively on X-ray images, catering to a wider range of initial radiographic screenings. The choice between them depends primarily on the imaging modality used and the specific anatomical focus for AI-assisted diagnosis.

Choose CINA-CSpine if…

Choose CINA-CSpine if your primary need is rapid, AI-powered triage and detection of acute cervical spine fractures specifically from non-enhanced neck CT scans. This tool is ideal for emergency departments and trauma centers seeking to enhance diagnostic accuracy and expedite patient care for critical spine injuries.

View CINA-CSpine →

Choose Rayvolve if…

Choose Rayvolve if your facility processes a high volume of X-rays for both adult and pediatric patients and requires a comprehensive AI solution for detecting a wide range of fractures and chest pathologies. This tool is best suited for improving efficiency and reducing interpretation time across general X-ray diagnostics in emergency medicine, orthopedics, and general radiology.

View Rayvolve →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CINA-CSpine Rayvolve
Pricing Subscription Subscription
Deployment Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) On-premise, on cloud, secure local processing and delivery of DICOM images (e.g., PACS); integration via AI marketplace or distribution platform.
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rayvolve

Rayvolve (Tool B) offers a significant advantage in processing speed, explicitly stating a processing time of less than one minute, and even under 10 seconds in some contexts. While both tools emphasize seamless integration into existing radiology workflows, CINA-CSpine (Tool A) has a stated processing time of 1-10 minutes, making Rayvolve faster for radiologists in their daily workflow.

Clinical Value

Rayvolve

Rayvolve (Tool B) demonstrates broader clinical utility by detecting both fractures and a comprehensive range of chest pathologies on X-rays for adult and pediatric patients. It also provides specific, quantifiable metrics such as a reduction in false negatives by up to 67% and a decrease in interpretation time by up to 27%. CINA-CSpine (Tool A) is specialized for cervical spine fractures on CT scans, with strong accuracy metrics, but its scope is narrower.

Pricing & Value

Tie

Both tools operate on a subscription model, but their pricing structures differ: CINA-CSpine (Tool A) is based on installations and users, while Rayvolve (Tool B) is based on the number of analyses [JSON, cite: 3, 9]. Without transparent public pricing details for either product, it is impossible to definitively assess which offers better value or a more cost-effective solution for a given healthcare institution.

Enterprise Readiness

CINA-CSpine

Both tools are FDA-cleared, HIPAA compliant, and offer flexible deployment options (cloud and on-premise) [JSON, cite: 3, 9, 14]. However, CINA-CSpine (Tool A) explicitly lists support for global healthcare data standards including DICOM, HL7, and FHIR [JSON], which are crucial for comprehensive enterprise integration. Tool A also indicates a 'likely' Business Associate Agreement (BAA) status, providing more transparency on data privacy compliance than Tool B's 'not specified' status [JSON].

Innovation

Rayvolve

Rayvolve (Tool B) exhibits greater innovation through its comprehensive AI suite, which covers a wider array of pathologies (fractures and various chest conditions) across different patient populations (adult and pediatric) and imaging modalities (X-rays) [JSON, cite: 9, 10]. This broad applicability and modular design (e.g., AZtrauma, AZchest) suggest a more versatile and adaptable AI solution compared to CINA-CSpine's (Tool A) focused application on cervical spine fractures on CT scans.

Support & Docs

Rayvolve

While both companies refer to documentation, Rayvolve (Tool B) explicitly mentions 'Rayvolve AI Suite documentation' and emphasizes a 'clear roadmap for post-deployment support' and 'governance documentation' as key attributes of a credible vendor. This suggests a more robust and transparent approach to providing comprehensive support and documentation, which is vital for long-term enterprise adoption and user confidence.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CINA-CSpine Rayvolve
Tool Name CINA-CSpine Rayvolve
Company Avicenna.AI AZmed SAS
Primary Modality & Pathology Acute cervical spine fractures on non-enhanced neck CT scans Fractures and chest pathologies on X-rays
Specialties Emergency Medicine, Neurosurgery, Radiology Emergency Medicine, Orthopedics, Radiology
Patient Age Range Not specified Adult and pediatric patients (u2265 2 years)
Key Feature Highlight Triage tool to automatically flag potential cervical spine fractures Comprehensive detection and triage capabilities for fractures and chest pathologies; reduction in interpretation time (up to 27%) and turnaround time (up to 83%)

Videos

Demos, reviews, and walkthroughs featuring CINA-CSpine and Rayvolve.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

AI Tool Finder
AI-powered search. Results may not be comprehensive.